Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Tuesday, January 26, 2021

Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients.

xlomafota13 shared this article with you from Inoreader
Related Articles

Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients.

Eur Arch Otorhinolaryngol. 2021 Jan 25;:

Authors: Haase K, Piwonski I, Stromberger C, Thieme N, Heiland M, Beck-Broichsitter B, Hofmann VM, Kofla G, Sander S, Keilholz U, Neumann K, Stölzel K, Olze H, Arens P, Dommerich S, Coordes A

Abstract
PURPOSE: The aim was to analyze the incidence and survival of patients living with HIV (PLWH) with head and neck squamous cell carcinoma (HNSCC) and to compare with a control group of HIV-negative HNSCC patients.
METHODS: Clinicopathological data and predictors for overall survival (OS) and disease-free survival (DFS) were investigated (2009-2019).
RESULTS: 50 of 5151 HNSCC patients (0.97%) were PLWH, and 76% were smokers. Age ≤ 60 years, HIV-PCR ≤ 50 copies, CD4 cells ≤ 200/mm3, cART treatment, T and UICC classification, oral cavity and nasal/paranasal sinuses, and therapy were significantly associated with OS in univariate analysis. In the multivariate analysis, only age and HIV-PCR independently predicted OS. The OS of the 50 PLWH was not significantly altered compared with the 5101 HIV-negative controls. However, OS and DFS were significantly inferior in advanced tumor stages of PLWH compared with an age-matched control group of 150 HIV-negative patients.
CONCLUSIONS: PLWH were diagnosed with HNSCC at a significantly younger age compared to HIV-negative patients. Taking into account patient age at initial diagnosis, both OS and DFS rates in PLWH are significantly worse compared with a matched control group of HIV-negative patients in advanced tumor stages UICC III/IV. The prognosis (OS) is improved when taking cART treatment, the HIV viral load is undetectable and CD4 count is high.

PMID: 33492419 [PubMed - as supplied by publisher]

View on the web

No comments:

Post a Comment